Emisphere Technologies, Inc. is a biopharmaceutical company that leverages its unique-absorption enhancing Eligen® Technology to both commercialize its own product candidates, and to license this proprietary drug delivery system to its partners.

Our core business strategy is to commercialize the Eligen® Technology through the launch of Rx Oral Eligen® B12 globally, expand our product pipeline and grow our delivery systems business through new and enhanced strategic alliances.



Copyright © Emisphere, All rights reserved